- Open Access
Is there a non-linear relationship between dietary protein intake and prostate-specific antigen: proof from the national health and nutrition examination survey (2003–2010)
Lipids in Health and Disease volume 19, Article number: 82 (2020)
Growing evidence demonstrated that dietary protein intake may be a risk factor for prostate cancer and elevate the level of prostate-specific antigen (PSA). However, proof for the correlation between dietary protein intake and PSA in American adults without prostate tumor history is limited. Our goal was to investigate the association of dietary protein intake with PSA using the National Health and Nutrition Examination Survey (NHANES) (2003–2010) database.
After the screening, 6403 participants were included in the study. The interested independent is the dietary protein intake, and the dependent variable is PSA levels, the covariates included demographic, dietary, biological data, and physical examination variables. A weighted linear model and a weighted linear regression model were used to examine the distribution of variables in the covariate differences between the different independent groups according to quartiles. Four models were used to survey the association between dietary protein intake and PSA. We also attempted to find a nonlinear relationship between dietary protein intake and PSA using the GAM model and the penalty spline method and further solved the nonlinear problem using weighted two-piecewise linear model.
The weighted multivariate linear regression analysis demonstrated that dietary protein intake was not independently associated with PSA levels after adjusting potential confounders (β = 0.015, 95%CI:-0.024, 0.055). However, we found the non-linear relationship between dietary protein intake and PSA, whose point was 18.18 g (per 10 g change). The magnitude and confidence intervals for the left and right inflection points are − 0.03 (− 0.09, 0.02) and 0.22 (0.07, 0.36), respectively. On the right side of the inflection point, one gram of increment in protein intake was associated with increased PSA levels by 0.22 (log2 transformation: 0.22, 95%CI: 0.07, 0.36).
After adjusting for potential covariates, the non-linear correlation between dietary protein intake and PSA was observed. When dietary protein intake exceeded the threshold of 181.8 g, dietary protein intake was positively correlated with elevated PSA levels.
Prostate cancer (PCa) remains the most commonly diagnosed cancer in men in the world. PCa is regarded as the second most common cause of cancer-related death for men in the world . In 2018, approximately 164,690 new cases and 29,430 deaths were estimated to be associated with PCa in the United States . The incidence rate of prostate cancer is higher in Western countries and it’s have risen sharply, together with mortality, in the past decades [3, 4]. A large number of studies strongly suggest that environmental factors play a key role in the pathogenesis of PCa. It is speculated that the prevalence of PCa in Western countries is largely due to the fundamental dietary characteristics of Western diet patterns [5, 6], which are characterized by high intake of protein and fat, as well as refined carbohydrates. Growing evidence indicated that dietary protein restriction (PR) diet is associated with lower PCa incidence [7, 8].
Due to the increasing incidence of PCa worldwide, strengthening early screening and diagnosis of PCa can help reduce mortality [3, 4]. The screening of PCa population is mainly based on Prostate-specific antigen (PSA). Therefore, the factors affecting PSA must be clarified to ensure the quality of screening and avoid missed diagnosis. PSA is a useful tumor marker for PCa and has been widely used as a screening tool for the disease [9, 10]. PSA is essentially a serine protease and has been widely used in clinical practice as a screening tool for PCa since 1988. It is the most well-known member of the Kalli-Kerin family with a 24% positive predictive value as a screening tool for the detection of PCa [11, 12]. Known recognized risk factors such as age, prostatitis, certain drugs such as 5-alpha reductase inhibitors (5ARIs) and prostate size can affect PSA levels . In recent studies, dietary protein restriction may affect PSA levels [14, 15]. Understanding how PSA is associated with specific mechanisms that contribute to cancer, such as changing dietary model, can improve future screening methods. To date, there is still a lack of evidence regarding the association of PSA and dietary protein intake in the general population. Therefore, we performed a secondary data analysis based on existing data that comes from the public NHANES data. We aim to explore the relationship between dietary protein intake and PSA level. In addition, we assessed whether an increase or change in protein intake would affect PSA levels.
Since 1960, the National Centers for Disease Control and Prevention (CDC) National Center for Health Statistics has conducted a National Health and Nutrition Examination Survey (NHANES) every two years to provide national estimates of the health and nutritional status of non-institutional populations in the United States. Data from the official website of NHANES (https://wwwn.cdc.gov/nchs/nhanes/Default.aspx) is available for free download. The NHANES protocol was reviewed and approved by the National Center for Health Statistics research ethics review board. All participants received written informed consent. More detailed information about NHANES can be found on the official website.
The NHANES database only has PSA data for 2003–2010, therefore we integrated data from four two-year NHANES survey cycles: 2003–2004, 2005–2006, 2007–2008 and 2009–2010, and performed secondary data analysis. We restricted the population included in the analysis to men 40 years of age and older and did not have a history of prostate tumor . They provided blood samples for PSA assessment as part of NHANES. The participants were screened according to the following exclusion criteria: (1) Men with prostate cancer, prostatitis, or recent prostate surgery (ie, a rectal exam within 1 week, and a prostate biopsy within 1 month, surgery or cystoscopy) were not included in the study. (2) We also excluded men who used 5ARI or other forms of hormone therapy (ie, testosterone replacement or medical castration) and drugs, with incomplete clinical or socio-demographic data. After a series of screening, 6403 out of 42,470 participants were included in the study. The detailed flowchart is shown in Fig. 1.
In the current study, the targeted independent variable was dietary protein intake (gm). The US Department of Agriculture (USDA) Automatic Multiple Pass Method (AMPM) was used to collect dietary intake data by interviewers 24 h a day. A detailed description of the dietary interview method has been described elsewhere . The targeted dependent variable was PSA (ng/mL). For the present study, serum PSA concentration (ng/mL) was measured using the Beckman Access Immunoassay System with the Hybritech Total PSA Assay (Beckman Coulter, Fullerton, CA) .
Covariates were selected based on previous studies demonstrating the link between these covariates and dietary protein intake and/or prostate cancer/PSA [16, 19]. Covariates included demographic, dietary, biological, and immunological variables. Variables included in the database file were as follows: continuous variables included LDL-cholesterol (mg/dL), Poverty income ratio (PIR), Body mass index (Kg/m2), Total alcohol intake on the first day (gm), Vitamin D (ng/mL), C-reactive protein(mg/dL), Glycohemoglobin (%), HDL-cholesterol (mg/dL), cigarettes per day during past month, Age (year), Total protein intake on the first day (gm) and Triglycerides (mg/dL). Categorical variables consisted of race, hypertension history, diabetes history, coronary heart disease, stroke, education level, marital status, physical activity, and enlarged prostate. In general, covariates relate to demographic data, dietary data, physical examination data, and comorbidities in the NHANES database. A more detailed explanation of the variables can be found on the NHANES official website.
Statistical analysis and missing data
We conducted a statistical analysis according to the criteria of the CDC guidelines (https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx). In order to enhance the statistical strength, we transformed the dietary protein intake by per 10 g change as the targeted independent variable, and we use log2 transformation and use the transformed data as the independent variable for data analysis because PSA is skewed distribution. Continuous variables were expressed as mean ± standard deviation (normal distribution) or median (quartile) (skewed distribution), and categorical variables were expressed in frequency or as a percentage. To investigate whether dietary protein intake is related to PSA levels in selected participants, our statistical analysis consists of three main steps. Firstly, the dietary protein intake was divided into four groups according to the quartile levels and presented the distribution of baseline data of patients included in this study in different dietary protein intake groups (Quartile). The chi-square tests (categorical variables), One –Way ANOVA (normal distribution), or Kruskal-Wallis test (skewed distribution) was used to demonstrate for differences among four quartile groups. In the second step of data analysis, the weighted univariate and multivariate linear regression model was employed. Four statistical models were constructed: model I, no covariates were adjusted; model II, only adjusted for socio-demographic data; model III, model 2 + other covariates exhibited in Table 1, model IV, a weighted generalized additive model (GAM). The third step of data analysis was to conduct the GAM model and smooth curve fitting (penalized spline method) to explore the nonlinearity association between dietary protein intake and PSA levels. If the GBM model detects nonlinearity, we first calculate the inflection point using a recursive algorithm and then construct a weighted two-stage linear regression model on both sides of the inflection point. We determined the best fit model based on the P-value of the log-likelihood ratio test (linear regression model and two piecewise linear regression models).
Missing data addressing is needed for the accuracy of data analysis because a series of variables in the NHANES database have different degrees of missing. If only using complete case for data analysis, it will cause a large number of samples to be lost and may produce bias in our findings. Therefore, we have adopted multiple interpolations, the main purpose of which is to maximize statistical power and minimize bias that might occur covariates with missing data were excluded from data analyses. We created 5 imputed datasets with chained equations using a mice software package. In addition, we used sensitivity analysis to identify whether created complete data had a significant difference from pre-imputation data. Our findings demonstrated that created complete data showed no significant difference from raw data. Therefore, all results of our multivariable analyses were based on the imputed datasets and were combined with Rubin’s rules.
To ensure the robustness of data analysis, we did the following sensitivity analysis: (1) we converted the dietary protein intake into a categorical variable by quartile and calculated the P for trend. The purpose was to verify the results of dietary protein intake as a continuous variable and to observe the possibility of nonlinearity; (2) we employed the weighted GAM model to adjust the continuous variables in model III.
All analysis was performed using statistical software R (http://www.r-project.org, The R Foundation) and EmpowerStats (http://www.empower-stats.com, X&Y Solutions, Inc., Boston, MA). A p-value of less than 0.05 (two-sided) was considered statistically significant.
Baseline characteristics of participants
Baseline characteristics of selected participants from NHANES 2003 to 2010 according to quartiles of dietary protein intake are exhibited in Table 1. There was no statistically significant difference the distribution of HDL, cigarettes per day during the past month and Enlarged prostate in four dietary protein intake groups (quartiles, Q1-Q4) (all p values > 0.0 5).
Compared to Q4 group, subjects with high dietary protein intake were older, had lower Vitamin D intake, LDH, Poverty income ratio, Body mass index, Alcohol first day, Protein first day and Triglycerides. In contrast, participants in other groups(Q1-Q3) has higher C-reactive protein and Glycohemoglobin levels, Physical activity, reported a higher incidence of hypertension, Diabetes, coronary heart disease, stroke. Most of the participants were Non-Hispanic White population.
Dietary protein intake and PSA levels
The magnitude of the correlation between Dietary protein intake and PSA levels was listed in Table 2. We used the imputation data to summarize the effect sizes of the Model 2, 3 and GAM models through Rubin rules (see Supplementary Tables 1 and 2 for details). Model 1 is an unadjusted model. Model 1 indicated that for each additional unit of dietary protein intake, the PSA level is reduced by 0.028 (0.036–0.021) with P for trend less than 0.05. In Model 2, after adjusting for socio-demographic variables (Race/Ethnicity, Poverty income ratio, Age, year, marital status, education level), the association between dietary protein intake and PSA level was not significant with P for trend > 0.05. In fully-adjusted mode, after adjusting for Vitamin D intake (mcg), LDL-cholesterol (mg/dL), Race/Ethnicity, Poverty income ratio, Body mass index (Kg/m2), Alcohol (gm) first day, C-reactive protein (mg/dL); Glycohemoglobin (%), HDL, Hypertension history, Diabetes history, coronary heart disease, stroke, cigarettes per day during past month, Age (year), Marital Status, Average level of physical activity each day, Enlarged prostate, Triglycerides (mg/dL), education level, marital status, the association between dietary protein intake and PSA level was still not significant with P for trend > 0.05. To solve the nonlinear problem, we also use GAM to adjust the continuous variables in the covariate. Despite these transformations (fitting continuous variables to smoothing), the results did not change significantly (model 4).
In order to make the results reliable, we did the following sensitivity analysis: enter X as a categorical variable to ensure the robustness of the results. Since the linear regression equation requires that all the independent variables and the dependent variable must have a linear relationship, when the relationship between the covariate and Y is nonlinear, the result may greatly deviate. Therefore, for the purpose of sensitivity analysis, we adjust all continuous variables in the covariate to the GAM model by the curve. However, although the magnitude and confidence interval of the effect values vary slightly, the direction is consistent with the fully-adjusted model. In addition, these transformations (fitting continuous variables to smoothing) was employed, the results still did not change significantly in the GAM model.
Based on the purpose of sensitivity analysis, dietary protein intake was stratified into a categorical variable by quartile and estimated P for trend (Table 2). In the fully adjusted model, compared with the reference Q1 group, the estimated increase of dietary protein intake in the Q2, Q3, and Q4 group were 0.238 (log2 transformation), − 0.552 and − 0.078, respectively. The P for trend was 0.47163. The results were consistent with the results of dietary protein intake as a continuous variable. Non-equidistant changes in the magnitude of this effect size (B) suggest a possible non-linear relationship between dietary protein intake and PSA.
Identification of non-linear relationship
In the study, the non-linear relationship between dietary protein intake and PSA was also explored (Fig. 2). Using the generalized additive model, the non-linear association between dietary protein intake and PSA was detected. The linear regression model and a two-piecewise linear regression model were compared, and the P for the log-likelihood ratio test is 0.002. This result demonstrates that the two-piecewise linear regression model should be used to fit the model.
By two-piecewise linear regression model and recursive algorithm, we calculated the inflection point was 18.18 g (per 10 changes) (Table 3). On the left of inflection point, the effect size, 95%CI and P value were − 0.03(log2 transformation) (− 0.09, 0.02) and 0.2721, respectively. On the right side of the inflection point, a positive association between dietary protein intake and PSA was observed, and the effect size, 95%CI and P value were 0.22(log2 transformation) (0.07, 0.36), P = 0.0040). There was somewhat U-shape between dietary protein intake and PSA with dietary protein intake threshold level of 181.8 g. These findings indicated that the threshold effect existed between dietary protein intake and PSA levels.
Prostate cancer (PCa) is the most common malignant tumor and the leading cause of cancer deaths for men in Western countries. Therefore, early screening of PCa is helpful for early detection, and early treatment reduces mortality. The current screening of PCa population is mainly based on PSA, so the clarification of the factors affecting PSA will help to improve the quality of screening. Previous literature reports that dietary protein intake is associated with PCa. In addition, there are also reports in the literature that dietary protein intake can affect PSA . Since previous literature has confirmed that dietary protein intake is associated with the development and progression of PCa [7, 8, 20], we speculate that dietary protein intake also affects the level of PSA. In order to verify our hypothesis, the USA NHANES database was used. The database is a large sample of databases that includes a variety of clinical and dietary, sociodemographic, laboratory, and questionnaire data. Therefore, the current work was to explore the relationship between dietary protein intake and PSA among American adults without prostate tumor history. As is shown in the fully adjusted weighted linear regression model (Table 2), dietary protein intake was not related to PSA. However, the non-linear relationship between dietary protein intake and PSA was observed, and the findings indicated that the correlation between dietary protein intake and PSA had a segmental trend. The different relationships of dietary protein intake on PSA were found on the left and right sides of inflection point (dietary protein intake per 10 change > 18.18 g). On the right side of the inflection point, dietary protein intake was positively associated with PSA, but the correlation on the left sides of the inflection point was not statistically significant.
Many studies have reported an association between dietary protein intake and PCa [7, 8, 20, 21]. The recent meta-analysis conducted by Mao Y et al. pooled 12 studies and the combined results revealed that protein intake may be not associated with prostate cancer , but in the study, the authors fail to evaluate the nonlinearity association. Fontana L et al. found that dietary protein restriction diet could significantly reduce BMI, increase insulin sensitivity and FGF21 concentration and produce a trend toward reduced PSA levels in human xenograft prostate models . In a randomized trial, Eitan E et al. also reported that dietary protein restriction modifies insulin signaling in circulating extracellular vesicles (EV), which indirectly reflect PSA levels . A study of the association between dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) a high intake of dairy protein may increase prostate cancer risk by increasing the production of insulin-like growth factor 1 (IGF-1, 21]. However, there was no strong evidence for the multiple interactions of a gene-dietary protein associated with PCa risk. Given that there is a lack of evidence between dietary protein intake and PSA. Therefore, we conducted a secondary study to confirm the hypothesis that higher dietary protein intake is associated with elevated PSA. In the work, we observed a non-linear relationship between dietary protein intake and PSA levels. When dietary total saturated fatty acids were greater than 65.12 g, the dietary protein intake was positively correlated with PSA levels.
Protein is composed of macromolecules made of amino acids and has basic functions in all known biologic processes. Data from epidemiological and human experimental studies suggest that dietary protein restriction is more powerful than calorie or fat restriction in lowering the circulating levels of IGF-1, which could inhibit the PI3K/AKT/mTOR pathway [14, 15]. In addition, IGF/PI3K/Akt/mTOR pathway play a key role in the pathogenesis of PCa [22, 23]. It is possible that the underlying mechanism delineating the association between dietary protein intake and PSA concentration is through IGF-1, which induced changed IGF-1 levels and inhibit the PI3K/AKT/mTOR pathway. Another potential mechanism, which has been supported by recent research, is that dietary protein decreases insulin sensitivity and promote prostate cancer cell tumor growth in animal models, which in turn affect the PSA levels [8, 24]. The potential biological mechanisms could explain the link between dietary protein intake and PSA levels.
The present study exhibited several strengths. Firstly, the research highlight of this study is its large sample size. The study included a large number of 6403 participants, which provides a high statistical power to quantitatively assess the association between dietary protein intake and PSA levels. Second, we have clearly clarified the missing data and performed multiple imputations. Our results demonstrate that there is no significant difference between the data before and after the interpolation, which improves statistical performance and minimizes the bias caused by missing records. Thirdly, we conducted linear and nonlinear regression model to increase comparability, and the results revealed the possibility of a non-linear relationship was detected. Fourthly, GAM was used to elucidate the non-linear relationship. Fifthly, we employed a strict statistical adjustment to minimize residual confounding, which could potentially influence the PSA. Finally, we calculated the inflection point by the recursive algorithm and discovered the saturation effect of dietary protein intake and PSA by two-piecewise linear regression, which provided protein recommendation for dietary guidelines.
The current work presents several limitations that must be considered in interpreting the results. Firstly, the study design was cross-sectional. Due to its inherent limitations, we are unable to derive a causal link between dietary protein intake and PSA was elucidated, and it is difficult to distinguish causality. Secondly, the research population is limited to the American, so the generalizability is geographically restricted. Thirdly, this study is based on a secondary analysis of published data so variables that are not included in the data set cannot be adjusted, such as dihydrotestosterone concentrations.
The association between dietary protein intake and PSA is non-linear. Dietary protein intake is positively correlated with PSA when PSA is larger than 181.8 g. Large prospective clinical trials with robust methodology are required to confirm our findings.
Availability of data and materials
Data can be downloaded from the ‘NHANES’ database (https://www.cdc.gov/nchs/nhanes/index.htm).
The National Health and Nutrition Examination Survey
Generalized Additive Model
Kuruma H, Egawa S. Words of wisdom: re: international variation in prostate cancer incidence and mortality rates. Eur Urol. 2013;63:583–4.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
Lopez Fontana CM, Recalde Rincon GM, Messina Lombino D, Uvilla Recupero AL, Perez Elizalde RF, Lopez Laur JD. Body mass index and diet affect prostate cancer development. Actas Urol Esp. 2009;33:741–6.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
Kolonel LN, Altshuler D, Henderson BE. The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer. 2004;4:519–27.
Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol. 2005;23:8152–60.
Fontana L, Adelaiye RM, Rastelli AL, Miles KM, Ciamporcero E, Longo VD, Nguyen H, Vessella R, Pili R. Dietary protein restriction inhibits tumor growth in human xenograft models. Oncotarget. 2013;4:2451–61.
Eitan E, Tosti V, Suire CN, Cava E, Berkowitz S, Bertozzi B, Raefsky SM, Veronese N, Spangler R, Spelta F, et al. In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles. Aging Cell. 2017;16:1430–3.
Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA. 2003;289:1414–20.
Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol. 2005;23:8146–51.
Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310–9.
Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320–8.
Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial. J Urol. 2005;174:877–81.
Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, Willett WC. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomark Prev. 2003;12:84–9.
Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92:1472–89.
Chang SL, Harshman LC, Presti JC Jr. Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and nutrition examination survey. J Clin Oncol. 2010;28:3951–7.
Moshfegh AJ, Rhodes DG, Baer DJ, Murayi T, Clemens JC, Rumpler WV, Paul DR, Sebastian RS, Kuczynski KJ, Ingwersen LA, et al. The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr. 2008;88:324–32.
Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, Dobs AS, Kanarek N, Nelson WG, Platz EA. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer. Prostate. 2015;75:1167–76.
Loprinzi PD, Kohli M. Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations: results from the National Health and nutrition examination survey (NHANES), 2003-2006. Mayo Clin Proc. 2013;88:11–21.
Mao Y, Tie Y, Du J. Association between dietary protein intake and prostate cancer risk: evidence from a meta-analysis. World J Surg Oncol. 2018;16:152.
Tsilidis KK, Travis RC, Appleby PN, Allen NE, Lindstrom S, Albanes D, Ziegler RG, McCullough ML, Siddiq A, Barricarte A, et al. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI breast and prostate Cancer cohort consortium (BPC3). Int J Cancer. 2013;133:495–504.
Raja Singh P, Sugantha Priya E, Balakrishnan S, Arunkumar R, Sharmila G, Rajalakshmi M, Arunakaran J. Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway. Mol Cell Biochem. 2017;427:69–79.
Mata R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway. Oncotarget. 2016;7:7683–700.
Kalaany NY, Sabatini DM. Tumours with PI3K activation are resistant to dietary restriction. Nature. 2009;458:725–31.
The authors would like to thank the NHANES databases for the availability of the data.
This work was supported by grants from the Science and Technology Plan Project of Guiyang in 2019 (2–15).
Ethics approval and consent to participate
NHANES protocol approved by the NCHS Research Ethics Review Board and obtained informed consent from all participants.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Additional file 1: Supplement table 1
. The description of missing data. Supplemental table 2: Sensitivity comparative analysis between pre-imputation and post-imputation.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Song, J., Chen, C., He, S. et al. Is there a non-linear relationship between dietary protein intake and prostate-specific antigen: proof from the national health and nutrition examination survey (2003–2010). Lipids Health Dis 19, 82 (2020). https://doi.org/10.1186/s12944-020-01234-6
- Dietary protein intake
- Prostate-specific antigen (PSA)
- NHANES database